These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35816059)

  • 1. Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice.
    Saceda-Corralo D; Moustafa F; Moreno-Arrones Ó; Jaén-Olasolo P; Vañó-Galván S; Camacho F
    J Drugs Dermatol; 2022 Jul; 21(7):742-747. PubMed ID: 35816059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's New in Therapy for Male Androgenetic Alopecia?
    Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
    Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive monocentric study.
    Vañó-Galván S; Saceda-Corralo D; Moreno-Arrones OM; Rodrigues-Barata R; Morales C; Gil-Redondo R; Bernárdez-Guerra C; Hermosa-Gelbard Á; Jaén-Olasolo P
    Dermatol Ther; 2020 Jan; 33(1):e13182. PubMed ID: 31820540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Cases of Paradoxical Nonscarring Alopecia after Mesotherapy with Dutasteride.
    Reguero Del Cura L; De Quintana Sancho A; Rubio Lombraña M; López Sundh AE; González López MA
    Skin Appendage Disord; 2022 Jan; 8(1):46-48. PubMed ID: 35118130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
    Melo DF; Saceda-Corralo D; Tosti A; Weffort F; Carla Jorge M; de Barros CC; de Melo Carvalho R; Starace M
    Dermatol Ther; 2022 Feb; 35(2):e15247. PubMed ID: 34877759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia.
    Tsunemi Y; Irisawa R; Yoshiie H; Brotherton B; Ito H; Tsuboi R; Kawashima M; Manyak M;
    J Dermatol; 2016 Sep; 43(9):1051-8. PubMed ID: 26893187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation.
    Moftah N; Moftah N; Abd-Elaziz G; Ahmed N; Hamed Y; Ghannam B; Ibrahim M
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):686-93. PubMed ID: 22486925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RF-Mesotherapy With Dutasteride: A Future Alternative Treatment for Androgenetic Alopecia.
    Reguero-Del Cura L; Durán-Vian C; de Quintana-Sancho A
    Actas Dermosifiliogr (Engl Ed); 2020 Jun; 111(5):419-420. PubMed ID: 32416936
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review.
    Herz-Ruelas ME; Álvarez-Villalobos NA; Millán-Alanís JM; de León-Gutiérrez H; Ocampo-Garza SS; Gómez-Flores M; Grimalt R
    Skin Appendage Disord; 2020 Nov; 6(6):338-345. PubMed ID: 33313048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair loss at injection sites of mesotherapy for alopecia.
    El-Komy M; Hassan A; Tawdy A; Solimon M; Hady MA
    J Cosmet Dermatol; 2017 Dec; 16(4):e28-e30. PubMed ID: 28160387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia.
    Boersma IH; Oranje AP; Grimalt R; Iorizzo M; Piraccini BM; Verdonschot EH
    Indian J Dermatol Venereol Leprol; 2014; 80(6):521-5. PubMed ID: 25382509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Female androgenetic alopecia, a survey of causes and therapeutic options].
    Duchková H; Hašková M
    Cas Lek Cesk; 2015; 154(2):90-4. PubMed ID: 25994911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angioedema-like contact dermatitis caused by mesotherapy with dutasteride.
    Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Alonso-Carpio M; Talamantes CS; Zaragoza-Ninet MG; Zaragoza-Ninet V
    Contact Dermatitis; 2020 Sep; 83(3):246-247. PubMed ID: 32356373
    [No Abstract]   [Full Text] [Related]  

  • 17. Alopecia secondary to mesotherapy.
    Duque-Estrada B; Vincenzi C; Misciali C; Tosti A
    J Am Acad Dermatol; 2009 Oct; 61(4):707-9. PubMed ID: 19577328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia.
    Melo DF; de Mattos Barreto T; Plata GT; Araujo LR; Tortelly VD
    J Cosmet Dermatol; 2020 Jan; 19(1):75-77. PubMed ID: 31066492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia.
    Tsai TF; Choi GS; Kim BJ; Kim MB; Ng CF; Kochhar P; Jasper S; Brotherton B; Orban B; Lulic Z
    J Dermatol; 2018 Jul; 45(7):799-804. PubMed ID: 29667763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current application of mesotherapy in pattern hair loss: A systematic review.
    Tang Z; Hu Y; Wang J; Fan Z; Qu Q; Miao Y
    J Cosmet Dermatol; 2022 Oct; 21(10):4184-4193. PubMed ID: 35253335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.